It was another wild week on Wall Street, but at the end of the week the Dow Jones Industrial Average (DJINDICES: ^DJI ) was up 0.88% and the S&P 500 (SNPINDEX: ^GSPC ) had gained 0.78%. Early in the week, stocks dropped because investors feared the Federal Reserve would taper off a bond-buying program that's helped keep interest rates low, but by the end of the week, losses had reversed on another pretty mediocre employment report.
Pfizer (NYSE: PFE ) led the Dow this week by gaining 3.8%. The company partnered with a company called CytomX to build antibody-drug conjugate products to fight cancer. The company can get an upfront payment of $25 million and a much as $610 million if sales goals are reached. Cancer drugs are really the next frontier for drug companies, and hopefully this is a winner for Pfizer. �
Verizon (NYSE: VZ ) was second in the Dow this week with a 3.6% gain -- surprising, considering how much the company was in the headlines. The Guardian broke a story about Verizon's cooperating with an NSA requirement to turn over information about both domestic and international phone calls, and another privacy debate erupted around the country. Verizon didn't have much of a choice considering the court order, so you can't really blame the company for cooperating. If we focus on the longer term, I think Verizon is still in prime position in the wireless market, and the NSA debate will grab headlines for only a short time. A 4.2% dividend yield and a wide competitive moat make this one of the best stocks on the Dow.
American Lorain Corporation (ALN), incorporated on February 4, 1986, is an integrated food manufacturing company. The Company develops, manufactures and sells food products, which includes chestnut products, convenience foods, including ready-to-cook (RTC) foods, ready-to-eat (RTE) foods and meals ready-to-eat (MRE)), and frozen food products. The Company conducts its production activities in China. Its products are sold in 26 provinces and administrative regions in China and 42 foreign countries. The Company derives its revenues from sales in China, Japan and South Korea. During the year ended December 31, 2011, the Company produced 254 products, including 16 new products in its chestnut and convenience foods segment. During 2011, it discontinued three products in the convenience segment. In February 2014, American Lorain Corp acquired a 51% interest in Athena Group.
The Company manufactures its products in six facilities in China, three of which are located in Junan County, Shandong Province, one in Luotian County, Hubei Province, one in Miyun County, Beijing City and one leased facility in Dongguan, Guandong Province. As of December 31, 2011, the Company manufactured its products using 26 production lines. Each production line is used to produce between 10 and 50 products. The Company operates three product lines: deep-freezing lines, canning lines and convenience food lines. The Company sells its products in all first-tier cities in China, including Beijing, Shanghai, Tianjin and Guangzhou. Its export sales destinations include Asia pacific, primarily Japan, South Korea and Malaysia, but also Singapore, Philippines, Indonesia and Australia; Europe, primarily Belgium and the United Kingdom, but also France, Germany, the Netherlands, Spain, Poland, and Denmark the Middle East, primarily Saudi Arabia, Kuwait and Israel; North America, including the United States and Canada.
ALN owns 100% of International Lorain Holding, Inc. (ILH). ILH wholly owns two Chinese operating subsi! diaries, Luotian Green Foodstuff Co., Ltd. (Luotian Lorain) and Junan Hongrun Foodstuff Co., Ltd. (Junan Hongrun), directly. Junan Hongrun, in turn, wholly owns Dongguan Green Foodstuff Co., Ltd. (Dongguan Lorain). In addition, together with Junan Hongrun, ILH wholly owns Beijing Green Foodstuff Co., Ltd. (Beijing Lorain), Shandong Greenpia Foodstuff Co., Ltd. (Shandong Greenpia), and owns approximately 80% of Shandong Green Foodstuff Co., Ltd. (Shandong Lorain) (Shandong Economic Development Investment Co. Ltd. owns approximately 20%).
Chestnut Products
During 2011, the Company produced 57 processed chestnut products. During 2011, this segment contributed 51.7% of its total revenues. The Company's products include its aerated open-bottom chestnuts, which are chestnuts packaged with nitrogen; sweetheart chestnuts, which are sweet preserved chestnuts; chestnuts in syrup, and golden chestnut kernels.
Convenience Foods
The Company's convenience food products include RTC food products, RTE food products and MRE food products. During 2011, the Company's RTCs included beef and lamb products, and its RTEs included bean products and pickle products. The Company's self heating MREs are primarily for military use since no cooking device or other ingredients are needed other than water. The Company also introduced microwavable MREs for civilian uses, such as camping, traveling and other situations. The Company produces various MREs based on Chinese cuisine, which include its pork with garlic sauce over rice and kungpao chicken with rice. The Company produced 138 convenience food products, during 2011, including 14 new products, such as filled buns and fried sweet potato.
Frozen Food Products
The Company produces a variety of frozen foods, including frozen vegetables, frozen fruits, frozen fish, and frozen meats. The Company produced 63 frozen food products in 2011. The Company's frozen foods included, during 2011, were frozen asparagus a! nd frozen! corn.
The Company competes with Hebei Liyuan, Foodwell Corporation, Weifang Langdong Food Co. Ltd., Yuyao Hongji Food Co. Ltd. and Yantai Pengshun Food Co. Ltd.
Advisors' Opinion: - [By James E. Brumley]
Truth be told, were it just today's 11% pop from American Lorain Corporation (NYSEMKT:ALN), it might not even be worth mentioning. It's not just today's 11% rally from ALN, though, that's made this stock so interesting. It's everything that's happened up until this point that may mean American Lorain deserves a spot at the top of your watchlist, if not in your portfolio.
Top 10 Rising Stocks For 2014: Actuate Corp (BIRT)
Actuate Corporation (Actuate), incorporated in November 1993, provides software and services to develop and deploy custom Business Intelligence and information applications. Actuate offers ActuateOne to develop and deploy Business Intelligence and Reporting Tools (BIRT)-based custom Business Intelligence and information applications focusing on browsers and mobile devices that deliver content hosted in cloud, software-as-a-service (SaaS) and on premises deployments. Its products and services are used by its customers to develop and deploy applications across a range of business functions, including financial management, sales management, account management, and customer self-service. Xenos solutions, based on Xenos Enterprise Server, loads, transforms and presents high volumes of data and documents across multiple channels. Actuate�� BIRT Spreadsheet products are Excel-based. In February 2014, Actuate Corporation announced the acquisition of legodo ag.
ActuateOne-Business Intelligence, Analytics and Reporting
Actuate offers a range of BIRT-based Business Intelligence (BI), analytics and reporting features within the integrated ActuateOne platform, providing 64-bit, in-memory analytics, user configurable dashboards, ad-hoc query, interactive mobile and Web content, brochure-quality reporting, and spreadsheet analysis. ActuateOne provides a platform upon which Global 9000 and packaged application software vendors develop and deploy BI and information applications. Such applications retrieve business information from databases, as well as print streams and deliver it as dashboards, interactive Web pages, spreadsheets, mobile content and analytic cubes to customers, partners and employees worldwide.
Xenos Enterprise Server Framework
Xenos Enterprise Server (ES) is an application that captures, identifies, routes, stores and retrieves structured and unstructured documents and data. Xenos ES supports the processing, extraction, transformation, repurposi! ng and personalization of structured and unstructured data in both legacy and SOA environments. Xenos ES distributes documents across multiple channels, such as Web, mobile and tablet devices in addition to providing interactivity and document analytics through its integration with ActuateOne.
Performance Analytics
Actuate BIRT Performance Analytics provides interactive dashboards, analytics, and scorecards. With Web interface, users across the enterprise can monitor operations, identify and analyze performance issues and enact initiatives.
BIRT Spreadsheet
Actuate�� BIRT Spreadsheet products deliver Excel-like reporting, formatting and calculation functionality within Java applications. Actuate BIRT Spreadsheet products can also leverage all the Actuate deployment options-embedded in applications or deployed cloud or on-premise enterprise environments.
The Company competes with Information Builders, Qlik Tech, Pentaho, Jaspersoft, MicroStrategy, IBM, Microsoft, Oracle and SAP.
Advisors' Opinion: - [By John Udovich]
Yesterday, small cap business intelligence stock MicroStrategy Incorporated (NASDAQ: MSTR) surged 18.44%�after reporting better-than-expected third quarter earnings ��meaning it might be a good idea to take a closer look at it�along with�small cap peers Actuate Corporation (NASDAQ: BIRT) and Qlik Technologies Inc (NASDAQ: QLIK) to see what they might offer small cap investors. After all, everyone is being inundated with huge amounts of data from multiple sources, but its the following small cap stocks that provide software platforms to help customers try to make sense of it all:�
- [By Roberto Pedone]
Actuate (BIRT) provides software solutions and services to corporate and government customers worldwide. This stock closed up 1.7% to $4.54 in Tuesday's trading session.
Tuesday's Range: $4.43-$4.57
52-Week Range: $3.41-$8.23
Tuesday's Volume: 213,000
Three-Month Average Volume: 319,262
From a technical perspective, BIRT trended modestly higher here back above its 50-day moving average of $4.51 with lighter-than-average volume. This move to the upside on Tuesday is starting to push shares of BIRT within range of triggering a major breakout trade. That trade will hit trigger if BIRT manages to take out some key overhead resistance levels at $4.60 to $4.75 and then above more resistance at $4.85 with high volume.
Traders should now look for long-biased trades in BIRT as long as it's trending above some key near-term support levels at $4.30 to $4.25 and then once it sustains a move or close above those breakout levels with volume that hits near or above 319,262 shares. If that breakout starts soon, then BIRT will set up to re-fill some of its previous gap-down-day zone from May that started near $6.
Top 10 Rising Stocks For 2014: InfoSonics Corp(IFON)
InfoSonics Corporation engages in the design, development, sourcing, and sale of wireless handsets and accessories in Latin America and the Asia Pacific. The company offers a line of entry-level, mid-tier, and high-end products under the verykool brand name. It contracts with electronic manufacturing services providers to manufacture its branded products. The company?s customers include carriers, agents, distributors, resellers, and original equipment manufacturers. InfoSonics Corporation was founded in 1994 and is headquartered in San Diego, California.
Advisors' Opinion: - [By Monica Gerson]
Infosonics (NASDAQ: IFON) shares jumped 22.64% to $2.06. Infosonics shares have jumped 170.97% over the past 52 weeks, while the S&P 500 index has gained 23.35% in the same period.
- [By Bryan Murphy]
Looking for some new trading ideas? Start by putting Arrowhead Research Corp. (NASDAQ:ARWR) and InfoSonics Corporation (NASDAQ:IFON) on your watchlist... though not yet in your portfolio. Though both IFON and ARWR have laid the foundation for a rally, neither has gotten above their final humps. Here's a closer look at what it's going to take.
Top 10 Rising Stocks For 2014: Tiffany & Co.(TIF)
Tiffany & Co., through its subsidiaries, engages in the design, manufacture, and retail of fine jewelry worldwide. Its jewelry products include fine and solitaire jewelry; diamond engagement rings and wedding bands for brides and grooms; and non-gemstone, sterling silver, gold, and platinum jewelry. The company also provides timepieces, sterling silver goods, china, crystal, stationery, fragrances, personal accessories, and leather goods. Tiffany & Co. sells its products through retail sales, Internet and catalog sales, business-to-business sales, and wholesale distribution primarily in the Americas, the Asia-Pacific, and Europe. The company also sells its products through its stores, as well as through department store boutiques in Japan. As of January 31, 2011, it operated 233 TIFFANY & CO. stores and boutiques worldwide. The company was founded in 1837 and is headquartered in New York, New York.
Advisors' Opinion: - [By Monica Gerson]
Analysts expect Tiffany & Co (NYSE: TIF) to report its Q1 earnings at $0.78 per share on revenue of $955.05 million. Tiffany shares climbed 0.87% to $89.00 in the after-hours trading session.
- [By Paul Ausick]
Big Earnings Movers: Tiffany & Co. (NYSE: TIF) is up 8.7% at $88.05 following positive results and a raised outlook. Barnes & Noble Inc. (NYSE: BKS) is down 6% at $15.45 as the bookseller watches its revenue slide. JA Solar Holdings Co. Ltd. (NASDAQ: JASO) is down 10.3% at $XX on a mixed earnings report and LDK Solar Co. Ltd. (NYSE: LDK) is flat at $1.60.
Top 10 Rising Stocks For 2014: PIMCO Municipal Income Fund III(PMX)
PIMCO Municipal Income Fund III is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Co LLC. It invests in fixed income markets. The fund invests in a portfolio of municipal bonds, including long and short U.S. Treasury Notes, and U.S. Treasury Bond Futures. PIMCO Municipal Income Fund III was formed in 2002 and is domiciled in United States.
Advisors' Opinion: - [By maarnio]
Spectral is focused on the development and commercialization of a treatment for severe sepsis utilizing its Endotox in Activity Assay (EAA) and the Toraymyxin therapeutic (PMX). If approved, this will be the first theranostics product, a targeted therapy guided by a specific diagnostic, in the area of sepsis. The company also manufactures and sells certain proprietary reagents.
Top 10 Rising Stocks For 2014: Durata Therapeutics Inc (DRTX)
Durata Therapeutics, Inc., incorporated on November 4, 2009, is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections (abSSSI). Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing. In addition to abSSSI, the Company focuses on the development of dalbavancin for additional indications, including osteomyelitis, diabetic foot infection and pneumonia.
As of December 31, 2011, Dalbavancin had already completed three Phase III clinical trials, in which more than 1,000 patients in total received dalbavancin. Dalbavancin achieved its primary efficacy endpoint of non-inferiority in each of these three completed Phase III clinical trials when compared to linezolid, cefazolin or vancomycin, three of the standard-of-care agents for uncomplicated skin and skin structure infections (uSSSI), and complicated skin and skin structure infections (cSSSI). Its two ongoing Phase III clinical trials are designed to compare dalbavancin to vancomycin, with an option to switch to oral linezolid, under the new FDA draft guidance.
The Company competes with Pfizer, Cubist Pharmaceuticals, Inc., Theravance, Inc., Forest Laboratories, Inc., Sanofi-Aventis Ltd., The Medicines Company, Trius Therapeutics, Inc., Cempra, Inc., Rib-X Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc., Nabriva Therapeutics AG, Tetraphase Pharmaceuticals, Inc. and Furiex Pharmaceuticals, Inc.
Advisors' Opinion: - [By Lisa Levin]
Durata Therapeutics (NASDAQ: DRTX) shares climbed 5.30% to $14.18. The volume of Durata Therapeutics shares traded was 861% higher than normal. The FDA Advisory Committee unanimously recommended the approval of Durata's Dalvance.
- [By Bob's Stocks]
Durata Therapeutics (DRTX) is developing Dalbavancin, a once a week, intravenous antibiotic product candidate, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. The company is expected to file a NDA (New Drug Application) at any moment and MAA (Marketing Authorization Application) at the end of 2013.
Top 10 Rising Stocks For 2014: Spirit Realty Capital Inc (SRC)
Spirit Realty Capital, Inc., incorporated on August 14, 2003, is a self-administered and self-managed real estate investment trust (REIT). The Company�� operations are carried out through Spirit Realty, L.P. (the Operating Partnership). The Company invests in single-tenant, operationally essential real estate throughout the United States that is leased on a long-term, triple-net basis primarily to tenants engaged in retail, service and distribution industries. Single-tenant, operationally essential real estate consists of properties that are generally free-standing, commercial real estate facilities where its tenants conduct retail, service or distribution activities. as of December 31, 2012, the Company�� portfolio of 1,122 owned properties were leased to approximately 165 tenants. In July 2013, the Company merged with Cole Credit Property Trust II.
The Company�� tenants operate in 18 different industries, which include medical/other office properties; recreational properties; educational properties; automotive dealers, parts and services facilities; industrial properties; building material suppliers; movie theatres; restaurants-casual dining; specialty retail properties; restaurants-quick service, and general and discount retail properties. The Company�� properties are geographically diversified across 47 states, with only 4 states contributing more than 5.0% of its annual rent. As of December 31, 2012, approximately 98.0% of its lease and loan revenues were attributable to long-term leases. As of December 31, 2012, the Company leases 181 properties to Shopko/Pamida, 179 of which are leased pursuant to three master leases.
Advisors' Opinion: - [By Rich Duprey]
With Spirit Realty Capital (NYSE: SRC ) set to merge with�Cole Credit Property Trust II in the third quarter, the commercial real estate REIT announced yesterday�it would pay a pro-rated dividend for the third quarter based on a quarterly payout of $0.3125 per share, the same rate it paid last quarter. Spirit only went public last September and began paying dividends in January.